Abstract
Circular RNAs(CircRNAs), a new class of non-coding RNAs, possess significant capabilities of gene regulation and are disrupted in various diseases, including diabetes mellitus (DM). However, the underlying mechanism of CircRNAs in DM and diabetic complications remains illusive. A recent study published by Liu et al. (Proc Natl Acad Sci USA 116:7455–7464, 2019) shown that a novel diabetic retinopathy (DR)-associated CircRNA cPWWP2A, which could act as a competing endogenous RNA interacting with miR-579 to promote the DR-induced retinal vascular dysfunction through up-regulating the expression of Angiopoietin 1, Occludin, and SIRT1. Their findings may provide new insight into the potential use of CircRNA cPWWP2A for the targeted therapy of DR. However, those promising findings may need to be further evaluated detailedly for the following reason. (1) This study doesn’t well clarify why the most significantly up-regulated CircRNA mmu _circ_0000254 the fold change of which is 160.581 is excluded,while the cPWWP2A the fold change of which is only 3.487 is chosen. (2) It is difficult to conclude that cPWWP2A competing with miR-579 only by the analysis of colocalization in pericytes.
Similar content being viewed by others
References
Daneshgari F, Moore C (2006) Diabetic uropathy. Semin Nephrol 26:182–185
He X, Ou C, Xiao Y, Han Q, Li H, Zhou S (2017) LncRNAs: key players and novel insights into diabetes mellitus. Oncotarget 8:71325–71341
He X, Li S, Yu B, Kuang G, Wu Y, Zhang M, He Y, Ou C, Cao P (2019) Up-regulation of LINC00467 promotes the tumourigenesis in colorectal cancer. Journal of cancer 10:6405–6412
Liu C, Ge HM, Liu BH, Dong R, Shan K, Chen X, Yao MD, Li XM, Yao J, Zhou RM, Zhang SJ, Jiang Q, Zhao C, Yan B (2019) Targeting pericyte-endothelial cell crosstalk by circular RNA-cPWWP2A inhibition aggravates diabetes-induced microvascular dysfunction. Proc Natl Acad Sci USA 116:7455–7464
Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P, Wu M (2017) CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer 16:94
Ou C, Sun Z, He X, Li X, Fan S, Zheng X, Peng Q, Li G, Li X, Ma J (2020) Targeting YAP1/LINC00152/FSCN1 Signaling Axis Prevents the Progression of Colorectal Cancer. Adv Sci (Weinh) 7:1901380
Shan K, Liu C, Liu BH, Chen X, Dong R, Liu X, Zhang YY, Liu B, Zhang SJ, Wang JJ, Zhang SH, Wu JH, Zhao C, Yan B (2017) Circular Noncoding RNA HIPK3 Mediates Retinal Vascular Dysfunction in Diabetes Mellitus. Circulation 136:1629–1642
Wang L, Kong L, Wu F, Bai Y, Burton R (2005) Preventing chronic diseases in China. Lancet 366:1821–1824
Zhong Y, Du Y, Yang X, Mo Y, Fan C, Xiong F, Ren D, Ye X, Li C, Wang Y, Wei F, Guo C, Wu X, Li X, Li Y, Li G, Zeng Z, Xiong W (2018) Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer 17:79
Zhou R, Wu Y, Wang W, Su W, Liu Y, Wang Y, Fan C, Li X, Li G, Li Y, Xiong W, Zeng Z (2018) Circular RNAs (circRNAs) in cancer. Cancer Lett 425:134–142
Acknowledgements
This work was supported by the National Natural Science Foundation of China (81903032).
Author information
Authors and Affiliations
Contributions
Conception and design: CL Ou, and QJ Yan. Writing, review, and/or revision of the manuscript: QJ Yan, XY He, and GY Kuang. Administrative, technical, or material support: J Yan, XY He, GY Kuang, and CL Ou.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing financial interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Qijia Yan and Xiaoyun He contributed equally to this work.
Qijia Yan and Xiaoyun He should be considered as co-first authors.
Rights and permissions
About this article
Cite this article
Yan, Q., He, X., Kuang, G. et al. CircRNA cPWWP2A: an emerging player in diabetes mellitus. J. Cell Commun. Signal. 14, 351–353 (2020). https://doi.org/10.1007/s12079-020-00570-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12079-020-00570-7